Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Dynamic iphone application development at low rates!
Popular Articles
Stretch Mark

Nç©ovacs To Expand Clinical Testing Of Its TNF-alpha Kinoid Lead Product Candidate Following Positive Preliminary Findings From A Phase I/II Study
Neovacs, a biotechnology company developing proprietary immunotherapeutics for autoimmune and chronic diseases, announced that subject to regulatory consent, it plans to initiate a Phase II study of its TNF-alpha Kinoid later this year in rheumatoid arthritis patients who have failed treatment with at least one TNF-alpha inhibitor. The decision to proceed with the trial was based on an initial review of encouraging data from the company"s Phase I/II study in Crohn"s disease.
generic viagra online
Chromosomal Problems Affect Nearly All Human Embryos; Discovery May Explain Low Fertility Rates In Humans
For the first time, scientists have shown that chromosomal abnormalities are present in more than 90% of IVF embryos, even those produced by young, fertile couples. Ms Evelyne Vanneste, a PhD student in the Centre for Human Genetics and the University Fertility Center, Leuven University, Belgium, told the 25th annual conference of the European Society of Human Reproduction and Embryology today (Wednesday July 1), that the surprising finding meant that current techniques used in preimplantation genetic screening (PGS), where embryos are screened genetically in order to select the best embryo for transfer, do nothing to improve pregnancy and live birth rates. Indeed, it can lead to potentially viable embryos being discarded, she said.
News of the day
What Is Lyme Disease? What Are Symptoms Of Lyme Disease?
Lyme disease was coined Lyme because it was first reported in three Connecticut towns, including Lyme and Old Lyme, in 1975. It was originally thought to be juvenile rheumatoid arthritis in these three towns. A study carried out by scientists from the Yale School of Public Health, USA and the University of Bath, England, revealed that "Lyme Disease In The U.S. Originated In Europe".
Diagnostics

General Practices Should Carry Out Majority Of Swine Flu Vaccinations

Australia"s general practices stand ready to work with Government to begin vaccinating vulnerable Australians against HINI (Swine Flu) as soon as a vaccine becomes available, the AMA said today. AMA Federal President, Dr Andrew Pesce, said general practices were the most logical venues to carry out the majority of Swine Flu vaccinations. "The Federal Government is to be congratulated for ordering 21 million doses of the Swine Flu vaccine, which is currently being developed," Dr Pesce said. "GPs and their practice nurses should be responsible for carrying out the vast majority of vaccinations. General practices have in place the required infrastructure, experience and local presence to carry out a large-scale vaccination program. "The Government needs to work with general practice groups to finalise plans to distribute the vaccine as quickly as possible. Vulnerable people such as pregnant women, those with chronic illnesses, the elderly and health workers who come into contact with patients suffering from swine flu should be vaccinated first." United General Practice Australia, which represents GP groups (including the AMA) and the National Aboriginal Community Controlled Health Organisation, recently urged the Federal Government to work with the medical profession to draw up plans to roll out the Swine Flu vaccine. Dr Pesce said many GPs were treating increasing numbers of patients with suspected or confirmed cases of Swine Flu. "While most cases of Swine Flu are mild, some patients, especially those with underlying health conditions, are becoming extremely ill. It"s important that GPs are able to begin vaccinating vulnerable patients as soon as possible," he said. The Government hopes to begin a nation-wide Swine Flu vaccination program in October. Australian Medical Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009